Onward Medical N.V. (EBR:ONWD)

Onward Medical Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	28.73	68.11	60.04	29.77	41.76	89.44
Short-Term Investments	52.78	-	-	-	20	-
Cash & Short-Term Investments	81.51	68.11	60.04	29.77	61.76	89.44
Cash Growth	99.13%	13.44%	101.70%	-51.80%	-30.95%	1301.49%
Accounts Receivable	1.86	1.2	0.16	-	-	-
Other Receivables	0.45	1.72	0.88	0.41	1.23	1.3
Receivables	2.31	2.92	1.04	0.41	1.23	1.3
Inventory	1.23	0.8	0.1	-	-	-
Other Current Assets	4.82	2.25	2.44	1.24	1.19	1.64
Total Current Assets	89.87	74.08	63.62	31.42	64.18	92.39
Property, Plant & Equipment	0.98	1.09	1.53	2.09	2.1	2.38
Goodwill	1.79	1.74	1.96	1.85	1.9	1.7
Other Intangible Assets	6.95	7	8.46	7.96	8.26	8.33
Long-Term Deferred Tax Assets	0.66	0.66	0.57	0.31	0.16	-
Total Assets	100.26	84.55	76.14	43.63	76.59	104.8

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.94	3.08	1.27	1.37	1.91	0.95
Accrued Expenses	-	4	3.24	1.73	2.32	1.9
Current Portion of Leases	0.26	0.54	0.6	0.57	0.43	0.47
Current Income Taxes Payable	0.19	0.18	0.2	0.22	0.22	0.08
Current Unearned Revenue	-	1	1.8	1.83	1.33	-
Other Current Liabilities	6.36	2.31	2.19	0.96	2.02	2.14
Total Current Liabilities	9.74	11.1	9.29	6.68	8.22	5.54
Long-Term Debt	13.51	13.07	13.97	15.26	12.66	11.45
Long-Term Leases	0.02	0.05	0.52	1.05	1.29	1.74
Pension & Post-Retirement Benefits	4.71	4.66	4	2.08	1.12	1.39
Long-Term Deferred Tax Liabilities	0.34	0.35	0.3	0.63	0.67	1.99
Total Liabilities	28.32	29.24	28.08	25.7	23.96	22.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8.34	6.72	5.36	3.62	3.62	3.62
Additional Paid-In Capital	302.11	264.35	217.77	155.25	155.25	155.25
Retained Earnings	-247.22	-222.56	-181.85	-145.43	-108.32	-75.97
Comprehensive Income & Other	8.7	6.8	6.77	4.49	2.08	-0.21
Total Common Equity	71.94	55.32	48.05	17.93	52.63	82.68
Shareholders' Equity	71.94	55.32	48.05	17.93	52.63	82.68
Total Liabilities & Equity	100.26	84.55	76.14	43.63	76.59	104.8

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.79	13.67	15.09	16.87	14.38	13.67
Net Cash (Debt)	67.72	54.45	44.96	12.89	47.38	75.78
Net Cash Growth	161.75%	21.11%	248.66%	-72.79%	-37.47%	-
Net Cash Per Share	1.26	1.17	1.01	0.43	1.57	7.99
Filing Date Shares Outstanding	69.53	56.01	44.63	30.18	30.18	30.18
Total Common Shares Outstanding	69.53	56.01	44.63	30.18	30.18	30.18
Working Capital	80.13	62.98	54.33	24.74	55.96	86.85
Book Value Per Share	1.03	0.99	1.08	0.59	1.74	2.74
Tangible Book Value	63.2	46.58	37.63	8.13	42.47	72.65
Tangible Book Value Per Share	0.91	0.83	0.84	0.27	1.41	2.41
Machinery	-	1.9	1.47	1.28	0.92	0.8
Leasehold Improvements	-	0.35	0.35	0.34	0.27	-

Data Source: S&P Global Market Intelligence Last updated: Sep 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error